Related Experiment Video
Updated: Feb 8, 2026

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
Dynamic Alterations in the Blood Transcriptome Characterize Drug Use Behavior and Co-Morbidities in Cocaine Use
Chinwe Nwaneshiudu1, Kiran Girdhar2,3, Steven P Kleopoulos2,3
1Department of Anesthesiology, Perioperative and Pain Medicine, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
This study developed a new pipeline to analyze blood transcriptome changes during cocaine abstinence. It reveals dynamic gene expression patterns linked to substance use and immune processes.
Area of Science:
- Neuroscience
- Genomics
- Computational Biology
Background:
- Cocaine use disorder (CUD) treatment is challenged by craving and relapse during abstinence.
- Longitudinal studies linking CUD behaviors to blood transcriptome changes are limited and complex.
- Developing novel analytical methods is crucial for understanding CUD recovery.
Purpose of the Study:
- To develop and validate an analytical pipeline for investigating the longitudinal relationship between drug use behaviors and blood transcriptome changes in individuals with CUD.
- To identify dynamic changes in gene expression associated with abstinence duration and behavioral outcomes.
- To provide a scalable approach for blood-based transcriptomic studies in substance use disorders.
Main Methods:
- A longitudinal study involving 12 subjects with CUD, collecting behavioral metrics and blood RNA-sequencing (RNA-seq) data at multiple time points (baseline, 3, 6, 9 months).
- Development of an analytical pipeline including hierarchical k-means clustering, in silico cell deconvolution, differential expression analysis over time, gene set enrichment analysis, and time-dependent gene co-expression analysis.
- Classification of subjects into responder groups based on behavioral scores and abstinence duration.
Main Results:
- The pipeline successfully captured dynamic changes in behavioral scores and abstinence duration within responder groups.
- Differentially expressed genes were enriched in genetic risk loci for substance use and cardiovascular diseases.
- Time-dependent gene co-expression analysis identified dynamic changes in immune processes, cell cycle, RNA-protein synthesis, and signaling pathways related to abstinence duration.
Conclusions:
- The study presents an innovative and scalable analytical pipeline for longitudinal blood-based RNA-seq studies in CUD, applicable to other substance use disorders.
- This data-driven approach enables the analysis of complex longitudinal drug use behaviors alongside blood transcriptomics.
- Significant changes in both drug use behaviors and the blood transcriptome were observed during cocaine abstinence.
Related Concept Videos
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...

